tenamfetamine
Small moleculeexperimental
3,4-Methylenedioxyamphetamine (MDA) is an entactogen, stimulant, and psychedelic drug of the amphetamine and MDxx families that is encountered mainly as a recreational drug. It is usually taken orally. — Wikipedia
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2009 (NCT00823407)
Timeline
No events for the selected filters.
Chemistry & pharmacology
Loading structure…
SMILES
CC(N)Cc1ccc2c(c1)OCO2- Mol. weight
- 179.22 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- Yes
- Chirality
- Racemic Mixture
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- Wikipedia3,4-Methylenedioxyamphetamine ↗
- ChEMBLCHEMBL6731 ↗
Also known as
- 3,4-methylenedioxyamphetamine
- 3,4-methylenedioxyamphetamine
- 3,4-methylenedioxyamphetamine
- tenamfetamine
- tenamfetamine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00823407 | N/A | Jan 1, 2009 | National Institute on Drug Abuse (NIDA), University of California, San Francisco |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute on Drug Abuse (NIDA) | Government | 1 | 0 | 1 | 2009 |
| University of California, San Francisco | Academic/Hospital | 1 | 1 | 1 | 2009 |
2 organizations
Page 1 / 1